Dominique Monnet
2017
In 2017, Dominique Monnet earned a total compensation of $2.4M as President at PDL BioPharma.
Compensation breakdown
| Option Awards | $1,459,114 |
|---|---|
| Salary | $155,303 |
| Stock Awards | $773,444 |
| Other | $25,301 |
| Total | $2,413,162 |
Monnet received $1.5M in option awards, accounting for 60% of the total pay in 2017.
Monnet also received $155.3K in salary, $773.4K in stock awards and $25.3K in other compensation.
Rankings
In 2017, Dominique Monnet's compensation ranked 4,601st out of 14,666 executives tracked by ExecPay. In other words, Monnet earned more than 68.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,601 out of 14,666 | 69th |
Division Manufacturing | 1,622 out of 5,768 | 72nd |
Major group Chemicals And Allied Products | 470 out of 2,074 | 77th |
Industry group Drugs | 362 out of 1,730 | 79th |
Industry Biological Products, Except Diagnostic Substances | 66 out of 316 | 79th |
Source: SEC filing on April 26, 2018.
Monnet's colleagues
We found five more compensation records of executives who worked with Dominique Monnet at PDL BioPharma in 2017.
2017
John McLaughlin
PDL BioPharma
Chief Executive Officer
2017
Danny Hart
PDL BioPharma
Vice President, Business Development
2017
Peter Garcia
PDL BioPharma
Chief Financial Officer
2017
Christopher Stone
PDL BioPharma
General Counsel
2017
Steffen Pietzke
PDL BioPharma